News & Media

Stay in the know
Research News

p53 mutations and cancer: Another twist in the tale

15 May 2023

Mutations affecting p53 are amongst the commonest genetic alterations in human cancer. Mutant p53 proteins are thought t...

Read More →
Media

A/Prof Polly Chen is nominated as the RNA Society’s Asian Research Ambassador

28 April 2023

A/Prof Polly Chen from N2CR and CSI Singapore has been nominated as this year’s RNA Society’s Asian Research Amb...

Read More →
Research News

Coffee with A/Prof Polly Chen

21 April 2023

A/Prof Polly Chen has been identified as an Asian RNA Research Ambassador by the RNA Society. Listen to her speak about ...

Read More →
Research News

Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds

12 April 2023

This comprehensive review describes the various therapeutic interventions using plant‐derived natural products and the...

Read More →
News

1st N2CR Staff Retreat 2023

11 April 2023

After 2 years, N2CR had its very first Staff Retreat! Held at the Republic of Singapore Yacht Club, our primary, seconda...

Read More →
Research News

Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas

3 April 2023

The accurate diagnosis of the most common small B-cell lymphoma histological subtypes can pose a significant challenge f...

Read More →
Research News

Novel Treatment Strategy for Gastric Cancer

3 April 2023

Gastric cancer with the development of peritoneal metastasis (cancer that has spread to the peritoneum) can be an incapa...

Read More →
Research News

Improving Patient Selection for Phase I Clinical Trials

3 April 2023

Phase I trials are an essential part of bringing new cancer therapies into the clinic. As participation in Phase I trial...

Read More →
Research News

Immunotherapy for Advanced Oesophageal Squamous Cell Carcinoma

3 April 2023

Immune checkpoint inhibitors (ICIs), a type of therapy which can greatly enhance the ability of the immune system to rec...

Read More →